Brief: Viva Biotech Sees Revenue To Reach RMB1,138 Mln For HY
17/08/2023 12:09
Aug 17 (Reuters) - VIVA Biotech Holdings 1873.HK :
* SEES REVENUE TO REACH RMB1,138 MILLION FOR SIX MONTHS
* SEES NET PROFIT OF NO LESS THAN RMB10.0 MILLION FOR HY
* EXPECTED RESULT DUE TO CHANGE IN PRODUCT MIX OF CONTRACT
DEVELOPMENT MANUFACTURE ORGANIZATION DURING HY
Further company coverage: 1873.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on VIVA Biotech Holdings
See all newsVIVA Biotech H1 profit falls on weaker investment income, FX headwinds
Brief: Viva Biotech Posts FY Net Profit RMB269.3 Million
Brief: Viva Biotech Received Declaration Letter
Brief: Viva Biotech Says Hangzhou Viva Zongchen Agreed To Invest RMB25.0 Million To Fund
Brief: Viva Biotech Passing Of U.S. FDA On-Site Inspection By Langhua Pharmaceutical